SMTL ID : 2gby.3 (3 other biounits)

Structure of QacR Multidrug Transcriptional Regulator Bound to Bivalent Diamidine Berenil

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.90 Å

Oligo State

homo-16-mer

Ligands

44 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 4 residues within 4Å: Chain A: Y.20, K.46, E.105, Y.106 Ligand excluded by PLIP SO4.2: 4 residues within 4Å: Chain A: E.13, I.16 Chain C: K.30, E.33 Ligand excluded by PLIP SO4.3: 4 residues within 4Å: Chain B: Y.20, K.46, E.105, Y.106 Ligand excluded by PLIP SO4.4: 4 residues within 4Å: Chain B: E.13, I.16 Chain D: K.30, E.33 Ligand excluded by PLIP SO4.5: 4 residues within 4Å: Chain C: Y.20, K.46, E.105, Y.106 Ligand excluded by PLIP SO4.6: 4 residues within 4Å: Chain A: K.30, E.33 Chain C: E.13, I.16 Ligand excluded by PLIP SO4.7: 4 residues within 4Å: Chain D: Y.20, K.46, E.105, Y.106 Ligand excluded by PLIP SO4.8: 4 residues within 4Å: Chain B: K.30, E.33 Chain D: E.13, I.16 Ligand excluded by PLIP SO4.10: 3 residues within 4Å: Chain F: N.2, D.5, K.6 Ligand excluded by PLIP SO4.11: 4 residues within 4Å: Chain F: K.4, Y.41, H.42 Chain G: K.17 Ligand excluded by PLIP SO4.12: 5 residues within 4Å: Chain F: V.29, S.35, K.36, G.37 Chain G: K.60 Ligand excluded by PLIP SO4.13: 4 residues within 4Å: Chain F: T.23, T.24, T.25, K.46 Ligand excluded by PLIP SO4.14: 2 residues within 4Å: Chain F: H.128, K.132 Ligand excluded by PLIP SO4.15: 5 residues within 4Å: Chain F: N.2, L.3, K.4, N.38, H.42 Ligand excluded by PLIP SO4.16: 3 residues within 4Å: Chain G: Y.40, T.45, K.46 Ligand excluded by PLIP SO4.17: 5 residues within 4Å: Chain G: L.8, K.12, I.53, I.56, E.57 Ligand excluded by PLIP SO4.18: 5 residues within 4Å: Chain F: K.36, Y.40 Chain G: N.2, D.5, K.6 Ligand excluded by PLIP SO4.20: 3 residues within 4Å: Chain I: N.2, D.5, K.6 Ligand excluded by PLIP SO4.21: 4 residues within 4Å: Chain I: K.4, Y.41, H.42 Chain J: K.17 Ligand excluded by PLIP SO4.22: 5 residues within 4Å: Chain I: V.29, S.35, K.36, G.37 Chain J: K.60 Ligand excluded by PLIP SO4.23: 4 residues within 4Å: Chain I: T.23, T.24, T.25, K.46 Ligand excluded by PLIP SO4.24: 2 residues within 4Å: Chain I: H.128, K.132 Ligand excluded by PLIP SO4.25: 5 residues within 4Å: Chain I: N.2, L.3, K.4, N.38, H.42 Ligand excluded by PLIP SO4.26: 3 residues within 4Å: Chain J: Y.40, T.45, K.46 Ligand excluded by PLIP SO4.27: 5 residues within 4Å: Chain J: L.8, K.12, I.53, I.56, E.57 Ligand excluded by PLIP SO4.28: 5 residues within 4Å: Chain I: K.36, Y.40 Chain J: N.2, D.5, K.6 Ligand excluded by PLIP SO4.30: 3 residues within 4Å: Chain L: N.2, D.5, K.6 Ligand excluded by PLIP SO4.31: 4 residues within 4Å: Chain L: K.4, Y.41, H.42 Chain M: K.17 Ligand excluded by PLIP SO4.32: 5 residues within 4Å: Chain L: V.29, S.35, K.36, G.37 Chain M: K.60 Ligand excluded by PLIP SO4.33: 4 residues within 4Å: Chain L: T.23, T.24, T.25, K.46 Ligand excluded by PLIP SO4.34: 2 residues within 4Å: Chain L: H.128, K.132 Ligand excluded by PLIP SO4.35: 5 residues within 4Å: Chain L: N.2, L.3, K.4, N.38, H.42 Ligand excluded by PLIP SO4.36: 3 residues within 4Å: Chain M: Y.40, T.45, K.46 Ligand excluded by PLIP SO4.37: 5 residues within 4Å: Chain M: L.8, K.12, I.53, I.56, E.57 Ligand excluded by PLIP SO4.38: 5 residues within 4Å: Chain L: K.36, Y.40 Chain M: N.2, D.5, K.6 Ligand excluded by PLIP SO4.40: 3 residues within 4Å: Chain O: N.2, D.5, K.6 Ligand excluded by PLIP SO4.41: 4 residues within 4Å: Chain O: K.4, Y.41, H.42 Chain P: K.17 Ligand excluded by PLIP SO4.42: 5 residues within 4Å: Chain O: V.29, S.35, K.36, G.37 Chain P: K.60 Ligand excluded by PLIP SO4.43: 4 residues within 4Å: Chain O: T.23, T.24, T.25, K.46 Ligand excluded by PLIP SO4.44: 2 residues within 4Å: Chain O: H.128, K.132 Ligand excluded by PLIP SO4.45: 5 residues within 4Å: Chain O: N.2, L.3, K.4, N.38, H.42 Ligand excluded by PLIP SO4.46: 3 residues within 4Å: Chain P: Y.40, T.45, K.46 Ligand excluded by PLIP SO4.47: 5 residues within 4Å: Chain P: L.8, K.12, I.53, I.56, E.57 Ligand excluded by PLIP SO4.48: 5 residues within 4Å: Chain O: K.36, Y.40 Chain P: N.2, D.5, K.6 Ligand excluded by PLIP

4 x BRN: BERENIL(Non-covalent)

BRN.9: 11 residues within 4Å: Chain E: F.162, E.165, Q.166 Chain F: Q.96, I.99, I.100, Y.103, E.120, I.124, N.154, N.157 12 PLIP interactions: 8 interactions with chain F, 4 interactions with chain E Hydrophobic interactions: F:Y.103, F:E.120, F:E.120, F:I.124, E:F.162, E:F.162, E:F.162 Hydrogen bonds: F:I.99, F:E.120, F:N.154, F:N.157, E:Q.166 BRN.19: 11 residues within 4Å: Chain H: F.162, E.165, Q.166 Chain I: Q.96, I.99, I.100, Y.103, E.120, I.124, N.154, N.157 12 PLIP interactions: 8 interactions with chain I, 4 interactions with chain H Hydrophobic interactions: I:Y.103, I:E.120, I:E.120, I:I.124, H:F.162, H:F.162, H:F.162 Hydrogen bonds: I:I.99, I:E.120, I:N.154, I:N.157, H:Q.166 BRN.29: 11 residues within 4Å: Chain K: F.162, E.165, Q.166 Chain L: Q.96, I.99, I.100, Y.103, E.120, I.124, N.154, N.157 12 PLIP interactions: 8 interactions with chain L, 4 interactions with chain K Hydrophobic interactions: L:Y.103, L:E.120, L:E.120, L:I.124, K:F.162, K:F.162, K:F.162 Hydrogen bonds: L:I.99, L:E.120, L:N.154, L:N.157, K:Q.166 BRN.39: 11 residues within 4Å: Chain N: F.162, E.165, Q.166 Chain O: Q.96, I.99, I.100, Y.103, E.120, I.124, N.154, N.157 12 PLIP interactions: 4 interactions with chain N, 8 interactions with chain O Hydrophobic interactions: N:F.162, N:F.162, N:F.162, O:Y.103, O:E.120, O:E.120, O:I.124 Hydrogen bonds: N:Q.166, O:I.99, O:E.120, O:N.154, O:N.157

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Brennan, R.G. et al., Structure of QacR Multidrug Transcriptional Regulator Bound to Trivalent and Bivalent Diamidine Drugs. To be Published

Release Date

2008-04-08

Peptides

HTH-type transcriptional regulator qacR: ABCDEFGHIJKLMNOP

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

B
D

C
D

D
D

E
B

F
A

G
E

H
B

I
A

J
E

K
B

L
A

M
E

N
B

O
A

P
E

HTH-type transcriptional regulator qacR

Related Entries With Identical Sequence